178 related articles for article (PubMed ID: 32801678)
1. Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps.
Afroz N; Gutzwiller FS; Mackay AJ; Naujoks C; Patalano F; Kostikas K
Int J Chron Obstruct Pulmon Dis; 2020; 15():1789-1800. PubMed ID: 32801678
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
Tabberer M; Brooks J; Wilcox T
Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
[TBL] [Abstract][Full Text] [Related]
3. Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.
Tabberer M; Lomas DA; Birk R; Brealey N; Zhu CQ; Pascoe S; Locantore N; Lipson DA
Adv Ther; 2018 Jan; 35(1):56-71. PubMed ID: 29313286
[TBL] [Abstract][Full Text] [Related]
4. Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
Donohue JF; Jones PW; Bartels C; Marvel J; D'Andrea P; Banerji D; Morris DG; Patalano F; Fogel R
Pulm Pharmacol Ther; 2018 Apr; 49():11-19. PubMed ID: 29277690
[TBL] [Abstract][Full Text] [Related]
5. Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.
Loubert A; Regnault A; Meunier J; Gutzwiller FS; Regnier SA
Int J Chron Obstruct Pulmon Dis; 2020; 15():2103-2113. PubMed ID: 32982203
[TBL] [Abstract][Full Text] [Related]
6. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy.
Matthys H; Funk P
Curr Med Res Opin; 2018 Jul; 34(7):1245-1251. PubMed ID: 29231073
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the association between exercise tests and patient-reported outcomes in patients with chronic obstructive pulmonary disease.
Punekar YS; Riley JH; Lloyd E; Driessen M; Singh SJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2487-2506. PubMed ID: 28860743
[TBL] [Abstract][Full Text] [Related]
9. Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?
Ekström M; Sundh J; Larsson K
Expert Rev Respir Med; 2016; 10(3):351-62. PubMed ID: 26808786
[TBL] [Abstract][Full Text] [Related]
10. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
12. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
14. Association between patient-reported outcomes and exercise test outcomes in patients with COPD before and after pulmonary rehabilitation.
Meys R; Stoffels AAF; Houben-Wilke S; Janssen DJA; Burtin C; van Hees HWH; Franssen FME; van den Borst B; Wouters EFM; Spruit MA;
Health Qual Life Outcomes; 2020 Sep; 18(1):300. PubMed ID: 32891156
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: a systematic review and meta-analysis.
Wu X; Hu X; Hu W; Xiang G; Li S
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368783
[TBL] [Abstract][Full Text] [Related]
16. Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: Patient-Centric Drug Development from Theory to Practice.
Patalano F; Gutzwiller FS; Shah B; Kumari C; Cook NS
Adv Ther; 2020 Jan; 37(1):17-26. PubMed ID: 31707715
[TBL] [Abstract][Full Text] [Related]
17. Airway clearance techniques for chronic obstructive pulmonary disease.
Osadnik CR; McDonald CF; Jones AP; Holland AE
Cochrane Database Syst Rev; 2012 Mar; (3):CD008328. PubMed ID: 22419331
[TBL] [Abstract][Full Text] [Related]
18. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD.
Partridge MR; Miravitlles M; Ståhl E; Karlsson N; Svensson K; Welte T
Eur Respir J; 2010 Jul; 36(1):96-104. PubMed ID: 19897551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
